Percutaneous catheter-based intracoronary infusion of insulin--a dose finding study in the porcine model

Basic Clin Pharmacol Toxicol. 2011 Jun;108(6):414-20. doi: 10.1111/j.1742-7843.2011.00672.x. Epub 2011 Feb 22.

Abstract

Insulin given at immediate reperfusion reduces myocardial infarct size in the in vitro and the ex vivo rat heart. In vivo, insulin may cause hypoglycaemia, hypokalaemia and elevation of catecholamines, potentially harmful during an acute myocardial infarction. The purpose of this study was to evaluate tolerance and safety of intracoronary insulin infusions in a porcine model applying percutaneous intervention techniques.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Glucose / drug effects
  • Cardiac Catheterization
  • Dose-Response Relationship, Drug
  • Electrocardiography / drug effects
  • Fasting
  • Female
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / pharmacology*
  • Hypoglycemic Agents / toxicity
  • Injections, Intra-Arterial
  • Insulin / administration & dosage
  • Insulin / pharmacology*
  • Insulin / toxicity
  • Maximum Tolerated Dose
  • Myocardial Infarction / drug therapy*
  • Myocardial Reperfusion*
  • Rats
  • Swine
  • Treatment Outcome

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin